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ABSTRACT
p100 protein (SND1, Tudor-SN) is a multifunctional
protein that functions as a co-activator for several
transcription factors, has a role in mRNA processing
and participates in RNAi-induced silencing complex
(RISC) with yet unknown function. In this study we
identified a novel function for p100 as a regulator of
angiotensin II type 1 receptor (AT1R) expression.
The binding of p100 to AT1R 3’-untranslated region
(3’-UTR) via staphylococcal nuclease-like (SN-like)
domains increased receptor expression by decreas-
ing the rate of mRNA decay and enhancing its trans-
lation. Overexpression of p100 increased AT1R
expression, whereas decrease in p100 binding to
3’-UTR either by p100 silencing or by the deletion
of p100 binding site downregulated receptor expres-
sion. The effect of p100 through AT1R 3’-UTR
was independent of Argonaute2 (Ago2), a known
p100 partner, and was thus RISC-independent.
Nucleotides 118 to 120 of the AT1R 3’-UTR were
found to be critical for the binding of p100 to
3’-UTR. In summary, p100 is a multifunctional regu-
lator of gene expression that regulates transcrip-
tion, mRNA maturation, and as described in this
article, also mRNA stability and translation.
INTRODUCTION
The control of mRNA stability is a potent regulatory
mechanism, because small changes in mRNA half-life
result in dramatic changes in the mRNA available for
translation. Such posttranscriptional regulation can be
achieved by diﬀerent means including mRNA processing,
nucleo-cytoplasmic export, mRNA localization, mRNA
stabilization and translational regulation (1,2). These
processes are mediated by conserved sequence elements
located in the untranslated regions (UTRs) of the
mRNA molecules together with speciﬁc mRNA-binding
proteins (RBPs) that can bind to and aﬀect mRNA
properties (2,3).
Recently it was demonstrated that microRNAs
(miRNAs) provide an additional posttranscriptional
mechanism by which protein expression can be regulated.
In animals, miRNAs usually control gene expression
through partial complementary elements in the 30-UTRs
of their target mRNAs (4–8). miRNAs are loaded onto
an Argonaute (Ago)-containing eﬀector ribonucleopro-
tein complex, referred to as RISC (RNA-induced silencing
complex), which is capable of recognizing cognate
mRNAs and inhibiting protein expression. All four mam-
malian Ago proteins associate with miRNAs and are
implicated in translational repression (9–11). However,
only Ago2 can mediate speciﬁc endonucleolytic cleavage
of a target mRNA (9,10,12).
Angiotensin II type 1 receptor (AT1R) is a G-protein-
coupled receptor that mediates most of the known
physiological actions of angiotensin II, including direct
pressor response, renal tubular sodium transport and
aldosterone secretion (13). Several recent studies suggest
that AT1R expression level is principally regulated by
posttranscriptional mechanisms (14–19), which are for
the most part mediated by the 30-UTR. When fused to a
reporter gene, the AT1R 30-UTR increases mRNA decay
and decreases AT1R mRNA translation. This eﬀect is
mediated by both RNA-binding proteins (RBPs) and
miR-155 (20–22), respectively.
During the course of the present study, we puriﬁed
AT1R 30-UTR-binding proteins from cytoplasmic
extracts, using AT1R 30-UTR as an aﬃnity probe.
One of these proteins was identiﬁed as p100 (SND1,
Tudor-SN). p100 protein consists of four similar domains
with homology to the staphylococcal nucleases (SN),
followed by a C-terminal Tudor (TD) domain showing
homology to the TD of Drosophila melanogaster tudor
gene (23). The SN-like domains of p100 have been
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mediate protein interactions (25). The TD is generally
found in proteins with putative functions in RNA binding
or protein binding during RNA metabolism and transport
(26,27). p100 was originally identiﬁed as a co-activator for
Epstein-Barr virus nuclear antigen 2 (EBNA-2) (28), but it
was now found to be a multifunctional protein with a role
in mRNA regulation.
Interestingly, p100 has been found also to be a part of
RISC, but p100 function in this complex has remained
unknown (24,29). In the present article we show that the
p100 interaction with 30-UTR leads to both stabilization
and enhanced translation of AT1R mRNA and this eﬀect
is independent of RISC pathway.
EXPERIMENTAL PROCEDURES
Cell culture, luciferase assay andprotein extraction
HEK293 and COS-1 cells were grown in DMEM that
was supplemented with 10% fetal bovine serum (FBS),
ampicillin/streptomycin and glutamine. Coronary artery
vascular smooth cells (VSMCs) were purchased from
Lonza Bioscience and cultured on smooth muscle growth
medium-2 with 5% FBS, ampicillin/streptomycin and glu-
tamine. Cells were used for 6–10 passages before replace-
ment with fresh early passage stocks. Expression
constructs were transiently transfected into HEK293
and COS-1 cells using a standard Fugene 6 protocol
(Roche). Silencing RNA for p100 (SND1) was from
Invitrogen. Other siRNAs and miRNAs including
siAgo2 (siEIF2C2), negative control siRNAs, partially
double-stranded RNAs that mimic endogenous precursor
miRNAs, hsa-miR-155 and miRNA Negative Control #1,
and also the anti-miR miRNA inhibitor anti-miR-155,
designed to inhibit endogenous miR-155, were all obtained
from Ambion. SiRNAs and miRNAs were transfected
using Lipofectamine2000 reagent (Invitrogen) according
to manufacturer’s instructions. Cells were harvested
24–72h after transfection and ﬁreﬂy luciferase activities
were measured using the Dual Luciferase Assay System
(Promega). The luciferase activity was normalized to the
activity of the cotransfected renilla luciferase plasmid.
Cytoplasmic protein lysates were prepared using TX100
lysis buﬀer (50mM Tris, pH 7.5, 10% glycerol, 150mM
NaCl, 1mM EDTA, 1% TX100 and protease and phos-
phatase inhibitors). VSMC were transfected as described
(30). For AT1R immunoprecipitation, proteins were
extracted from 10
7 of VSMCs with 1% TX100, 0.5%
SDS, 0.5% sodiumdeoxycholate. Protein concentrations
were determined by Bradford assay (Rio-Rad).
Constructs
The coding region of human AT1R was ampliﬁed by a
proofreading Pfu polymerase from a HeLa cDNA library,
and sequenced to certify authenticity. All the luciferase
and AT1R constructs were based on pGL3 (Promega)
vector. 30-UTR (nucleotides 1–887, respectively) was
cloned into a XbaI–XbaI site downstream of the luciferase
or AT1R coding region (in pGL3 vector luciferase was
replaced with AT1R). A simple TATA promoter with
an enhancer was added to upstream of the luciferase
coding region and the SV40 late polyA signal was
added downstream of the 30-UTR sequence. Progressive
deletions of AT1R 30-UTR were generated using a PCR-
based technique. Luciferase constructs expressing AT1R
30-UTR mutants were generated by PCR-based ampliﬁca-
tion of a fragment followed by subcloning into 30-UTR.
The orientation and sequence of all constructs were
conﬁrmed by sequencing. The pSG5 vector expression
plasmids containing full-length p100, SN-like domains
(aa 1–639) or TD (aa 640–855) tagged with Flag sequence
were generated as previously described (31).
Real-time PCR
In RNA half-life experiments, COS-1 cells were immersed
in fresh media containing 1mg/ml actinomycin D (Tocris)
to inhibit transcription and incubated at 378C. At the indi-
cated times, cells were harvested and total cellular RNA
was extracted with Nucleospin RNA II kit (Macherey-
Nagel). RNA was treated with DNase I (Ambion). The
ﬁrst-strand cDNA was synthesized with Superscript II
First Strand Synthesis System for RT-PCR and
oligo(dT)12–18 primer (Invitrogen). Primer sequences used
for PCR ampliﬁcation of GAPDH and b-actin genes
have been published earlier (32,33). AT1R oligos used
were gcacaatgcttgtagccaaa (upstream) and ccctatcggaagg
gttgaat (downstream). After the ﬁrst strand cDNA syn-
thesis, serial dilutions were made. The PCR reactions
were performed according to manufacturer’s instructions.
The annealing temperatures were 598C for GAPDH oligos
and 608C for AT1R and b-actin oligos. The ﬂuorescence
emitted by SYBR Green I was measured in every cycle
at the end of the elongation step. The second derivative
maximum method was used to determine the crossing-
point values. The concentrations of unknown samples
were then calculated by setting their crossing points to
the standard curve. For normalization of the expression
levels, the expression of GAPDH or b-actin was measured.
The relative expression level was obtained by dividing the
values for the gene of interest with the GAPDH or b-actin
value. In addition to the melting curve information
obtained from the LightCycler, the PCR products were
run in agarose gel electrophoresis to ensure that only
a right-sized product was ampliﬁed.
MicroRNA isolation anddetection
MicroRNAs were extracted by using mirVana miRNA
Isolation Kit (Ambion). MirVana qRT–PCR miRNA
Detection Kit with primer sets for miR-155 and loading
control 5S rRNA was used for detection of isolated RNAs
according to manufacturer’s instructions (Ambion).
RNA probepreparation
cDNA was used as a template for PCR reactions whereby
T7 RNA polymerase promoter sequence was added to the
50-end of all fragments. RNA transcripts were synthesized
from PCR-generated templates including the following
30-UTR regions: 1–100, 1–300, 1–600, 1–857 (full length
30-UTR) as well as from 100 to 300, 300 to 600, 600 to 857,
100–200, 150–250, 118–200, and 121–200 (MEGAscript,
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probes 30 bases long polyA tail was included in the 30-
oligos described above. RNA probes with or without
biotin label (bio-11-UTP, Ambion) were generated by
MEGAshortscript or MEGAscript kit according to man-
ufacturer’s instructions (Ambion). Transcription reaction
was run at least for 2h and then the products were run on
denaturing PAGE. The gel was stained with SYBR Green
II RNA gel stain (Molecular Probes, Invitrogen) and the
band corresponding to the correct size was excised and
eluted with 500ml of 0.5M ammonium acetate, 10mM
magnesium acetate, 1mM EDTA, 0.1% SDS followed
by phenol-chloroform extraction and ethanol
precipitation.
RNA affinitypurification
Two micrograms of in vitro transcribed polyadenylated
RNA probes were incubated with polystyrene latex
beads with dC10T30 oligonucleotides covalently linked to
the surface (Oligotex, Qiagen), in a buﬀer containing
20mM Tris–HCl, pH 7.5, 1M NaCl, 2mM EDTA and
0.2% SDS. After 2 washes in a wash buﬀer 10mM
Tris–HCl, pH 7.5, 150mM NaCl and 1mM EDTA, the
RNA-coated beads were incubated with 100–250mg cyto-
plasmic extracts in the RNA-binding buﬀer (5mM Hepes,
pH 7.9, 7.5mM KCl, 0.5mM MgCl2, 0.1mM EDTA,
0.5mM dithiotreitol (DTT), 0.1mg/ml yeast tRNA,
0.1mg/ml bovine serum albumin, BSA). After incubation
for 30min on ice, the beads were extensively washed with
RNA-binding buﬀer without BSA. Proteins bound to the
RNA probe were resolved on 4–20% SDS–PAGE and
subjected either to silver staining according to the manu-
facturer’s instructions (Silver Stain Plus, Bio-Rad) or to
western blotting.
Massspectrometry
Silver stained protein bands of interest were cut out of
the SDS–PAGE gel and ‘in-gel’ digested essentially as
described by Shevchenko et al. (34). Proteins were reduced
with DTT and alkylated with iodoacetamide before
digestion with trypsin (Sequencing Grade Modiﬁed
Trypsin, V5111, Promega). The recovered peptides were,
after desalting using Millipore C18 ZipTip
TM, subjected to
matrix-assisted laser desorption/ionization-time of ﬂight
(MALDI-TOF) mass spectrometric analysis. MALDI-
TOF mass spectra for mass ﬁngerprinting and MALDI-
TOF/TOF mass spectra for identiﬁcation by fragment
ion analysis were acquired using an Ultraﬂex TOF/TOF
instrument (Bruker-Daltonik GmbH, Bremen, Germany).
Protein identiﬁcation with the generated data was per-
formed using Mascot Peptide Mass Fingerprint and
MS/MS Ion Search programs (http://www.matrix
science.com).
Antibodies, immunoprecipitation (IP) and western blotting
Antibodies used in IPs and western blotting were as
follows: polyclonal anti-p100 (C-17, Santa Cruz), poly-
clonal anti-Ago2 (Upstate), monoclonal anti-Flag
(Sigma), polyclonal anti-Luciferase (Abcam), monoclonal
anti-AT1R (TONI-1, Abcam), and monoclonal anti-
b-tubulin (Upstate). IPs were performed with speciﬁc
primary antibodies for 2h at 48C, followed by incubation
with protein G Sepharose beads (Amersham Pharmacia
Biotech) for 30min at 48C, and several washes with the
TX100 lysis buﬀer. Aﬃnity-puriﬁed proteins, IPs and cell
lysates were electrophoresed in 4–20% SDS–PAGE and
transferred into nitrocellulose membrane (Hybond ECL).
Immunodetection was performed using speciﬁc anti-
bodies, followed by incubation with biotinylated second-
ary antibodies (Dako Cytomation), streptavidin-biotin
HRP-conjugated secondary antibodies (Amersham
Biosciences), and enhanced chemiluminescence (ECL,
Amersham).
Purification of Flag-tagged proteins
Immunoaﬃnity puriﬁcation of Flag-tagged p100, SN-like,
and TD proteins was performed with Flag aﬃnity resin
according to manufacturer’s instructions (Sigma).
Table 1. Primers used in the generation of PCR products that served as templates in in vitro transcription. Numbering
starts from the beginning of 30-UTR
AT1R 30-UTR sense primers (number denotes the ﬁrst nucleotide of the 30-UTR included in the oligo)
1 TAATACGACTCACTATAGGG catgttc gaaacctgtc cataaagtaa ttttgtgaaa gaagg.
100 TAATACGACTCACTATAGGG gaattga aggagaaaat gcattatgtgg
118 TAATACGACTCACTATAGGG cattatgtg gactgaaccg acttttctaa
121 TAATACGACTCACTATAGGG tatgtg gactgaaccg acttttctaa
150 TAATACGACTCACTATAGGG tctgaac aaaagctttt ctttccttttgcaacaagac
300 TAATACGACTCACTATAGGG agcctgc ttttgtcctg ttatttttta tttccacata aagg
600 TAATACGACTCACTATAGGG gtataat ggtgttacta aagtcacata taaaagttaa ac
AT1R 30-UTR antisense primers (number denotes the last nucleotide included in the oligo)
100 ctgaaaagta gctaatgctc atttggtagt gaag
200 tgtggctttgctttgtcttgttgc
250 attcatcgagtttctgacattgttcttcgagcagcc
300 cagtaaaatt tctcaaatca acacattcat cgagtttc
600 attgttttgg cagtgtaaac ctataagaca caggttg
857 aaacaggaag gcatacttta tgatatataa tctttttaccac
Control (part of the luciferase coding region)
S TAATACGACTCACTATAGGG gcgccattctatccgctggaagatggaacc
AS cgcccaacaccggcataaagaattgaagag
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REMSA was performed incubating biotinylated probes
together with immunoaﬃnity-puriﬁed p100-Flag,
SN-Flag and TD-Flag proteins. In brief, 100ng of diﬀer-
ent Flag-tagged proteins were incubated with 1mgo f
30-UTR probe in 5mM Hepes, pH 7.9, 7.5mM KCl,
0.5mM MgCl2, 0.1mM EDTA, 0.5mM DTT, 0.1mg/ml
yeast tRNA, 0.1mg/ml BSA for 30min on ice. The
unbound probe was digested with RNAse A for 1h at
RT. Glycerol was added to the mixture and the samples
were separated by 6% native PAGE with 0.5 Tris
borate-EDTA (TBE) running buﬀer. The gels were incu-
bated in 5 SSC/10mM NaOH for 30min, in 1 TBS,
pH 7.6 for 2 15min and in 1 TBE for 30min. Finally
the binding products were transferred from gels into
BrightStar-Plus nylon membranes, followed by detection
with BrightStar Biodetect (Ambion).
Protein IP forAT1R mRNA detection
The assay was performed essentially as described (35).
In this assay, p100-Flag was immunoprecipitated from
a cytoplasmic lysate prepared from 10
7 of COS-1 cells
with the use of 1mg of anti-Flag antibody or with unre-
lated IgGs as a negative control. The samples were ﬁrst
precleared with protein G Sepharose beads. p100-Flag was
then immunoprecipitated after which protein G Sepharose
beads were added. The IPs were extensively washed with
100mM KCl, 5mM MgCl2, 10mM HEPES, pH 7.0, 0.5%
NP-40, 1mM DTT and 100 U/ml RNasin RNAse inhibi-
tor as well as 2mM vanadyl ribonucleoside complexes
solution (Sigma) and protease and phosphatase inhibitor
cocktails. Proteins were digested with 0.1% SDS and 30mg
of proteinase K followed by RNA extraction with phenol-
chloroform-isoamyl alcohol mixture. RNA was precipi-
tated with 10mg of yeast tRNA as a carrier. RT–PCR
was then performed with poly-dT oligos, followed by
PCR reactions with primers for coding region of AT1R
mRNA or for b-actin for normalization (as described in
real-time PCR section). The PCR products were separated
on agarose gel.
In vitro translation
In vitro translation reactions were performed using
Flexi Rabbit Reticulocyte Lysate System (Promega) as
instructed by the manufacturer. Proteins synthesized
in vitro were labelled with biotinylated lysine tRNA.
A 100ng of BSA control or immunoaﬃnity-puriﬁed
p100 was added to each translation reaction. The results
were evaluated by luciferase assay as well as by western
blotting. In the western blot, the in vitro translation
products were detected using streptavidin-HRP antibodies
according to manufacturer’s protocols (Promega).
35Slabelling
For
35S labelling COS-1 cells were transfected either with
p100-Flag, sip100 or with appropriate controls. After 72h,
100mCi/ml of
35S-methionine was added and the cells were
incubated for additional 7h. Cells were then lysed and
subjected to luciferase IP with anti-luciferase antibody,
followed by SDS–PAGE and autoradiography.
Ligandbinding assay
AT1R binding was measured using subconﬂuent cells
grown in 24-well plates. The assay was performed as
described previously (36).
RESULTS
p100interacts withAT1R 3’-UTR
To search for proteins that bind to AT1R 30-UTR, we
performed protein separation from HEK293 cell lysates
by RNA aﬃnity puriﬁcation with full-length AT1R
30-UTR probe. The 100kDa band, seen only in the lane
corresponding to binding products with the 30-UTR
probe, was identiﬁed by mass spectrometry as p100
(Figure 1A). The association of AT1R mRNA with p100
was monitored by extracting RNA from the IP material
and subjecting it to reverse transcription (RT) and
quantitative real-time PCR analysis. Because the expres-
sion of AT1R is very low in COS-1 and HEK293 cells and
because the commercial p100 antibodies did not immuno-
precipitate p100, we transfected cells with p100-Flag
together with a construct where AT1R coding region
was fused to 30-UTR, and made IPs with anti-Flag anti-
bodies under conditions that retained the integrity of ribo-
nucleoprotein (RNP) complexes. As shown in Figure 1B,
the AT1R PCR product was dramatically enriched in
p100 IP samples compared with control IgG IP samples.
Also endogenous AT1R was co-precipitated with p100-
Flag with 4-fold diﬀerence to control (data not shown).
The ampliﬁcation of b-actin PCR product was found in all
samples and this low-level contaminating housekeeping
transcript served to monitor the evenness of sample
input. These data indicate that p100 forms RNP complex
with AT1R mRNA.
To identify the AT1R 30-UTR region recognized by
p100, we performed aﬃnity puriﬁcation assays with
RNA probes corresponding to diﬀerent regions of the
30-UTR from p100-Flag overexpressing COS-1 cell lysates.
We saw that the full-length 30-UTR had the highest aﬃn-
ity for p100 and 100–300 region was suﬃcient for p100
binding (Figure 1C).
SN-like domainsof p100 mediate theinteraction with
3’-UTR andhave abroader binding specificity than
full-length p100
SN-like domains of p100 have been known as protein-
interaction domains (25), and recently they were shown
to mediate RNA interactions also (37). The TD is found
in proteins with putative functions in RNA binding or
protein binding (26,27). Next, we evaluated the interac-
tion of SN-like domains and TD with 30-UTR. To study
the binding of diﬀerent domains of p100 to 30-UTR,
we performed aﬃnity puriﬁcation reactions with diﬀerent
30-UTR transcripts. The anti-Flag western blot (Figure 2A,
upper panel) demonstrated that SN-like domains medi-
ate the interaction with 30-UTR, whereas TD showed
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region, being the principal interaction area for full-length
p100, SN-like domains bind strongly also to 30-UTR bases
in the 300–600. It might be that although TD does not
directly interact with the 30-UTR, it is important for the
binding speciﬁcity of p100.
REMSA confirmsthe p100 interaction with
100–300region ofAT1R 3’-UTR
To conﬁrm the binding of p100 and SN-like domains to
100–300 region, we performed electrophoretic mobility-
shift assay (REMSA). We ﬁrst puriﬁed TD and SN-like
domains using GST system, but we did not observe any
binding of either domains with AT1R 30-UTR with this
approach. The absence of interaction may be due to the
labile nature of the p100-AT1R mRNA complex, improper
folding of p100 domains in bacterial cells or lack of other
binding proteins needed for the interaction. Due to these
problems, we used aﬃnity-puriﬁed Flag-tagged proteins.
The proteins were incubated with biotinylated probes
corresponding to negative control transcript or speciﬁc
100–300 transcripts. The unbound probe was digested
and the interaction between the transcript and diﬀerent
domains or full-length p100 was assessed by REMSA.
The negative control transcript did not show any
gel shift in the absence or presence of p100, SN-like
domains or TD (Figure 2B, upper panel). In contrast, the
100–300 fragment of AT1R 30-UTR showed a strong shift
with full-length p100 and SN-like domains. This result
indicated that SN-like domains mediate the interaction of
p100 with 100–300 region of 30-UTR.
p100 and Ago2 co-immunoprecipitate and bothbind
to 100–300region ofAT1R 3’-UTR
Because of the published interaction of p100 with Ago2,
we tested for the presence of Ago2 in 30-UTR aﬃnity
puriﬁcations. As shown in Figure 3A, Ago2 was found
to aﬃnity purify with the same set of probes as p100.
In addition, the binding of Ago2 was further increased
when p100 was overexpressed. Ago2 was also found to
be present in immunoaﬃnity-puriﬁcation reactions with
full-length p100 and SN-like domains (Figure 3B, upper
panel). Thus, it seems that Ago2 binds to AT1R 30-UTR
in complex with p100 and that SN-like domains are criti-
cal for this interaction.
p100 bindingto 100–300region of AT1R 3’-UTR
is Ago2 independent
Given that p100 binds 30-UTR in complex with Ago2,
we next tested whether p100 binding to 100–300 region
of AT1R 30-UTR is due to the RNA binding of Ago2 or
vice versa. For this purpose we silenced either Ago2
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Figure 1. p100 interacts with AT1R 30-UTR. (A) Search for AT1R 30-UTR-binding proteins using aﬃnity puriﬁcation. The details of the puriﬁcation
are given under ‘Experimental Procedures’. A negative control probe (Neg) consisting of the segment of luciferase coding region and a probe
corresponding to nucleotides 1–857 of AT1R 30-UTR (30-UTR) were incubated with HEK293 cell lysates and run into SDS–PAGE, which was then
silver-stained. The diﬀerentially expressed 100kDa protein was analysed by mass spectrometry. (B) Ampliﬁcation of AT1R mRNA from p100 IPs.
p100-Flag was immunoprecipitated with anti-Flag antibody or control IgG. RNA was extracted from the IPs, subjected to RT–PCR, followed by
quantitative PCR analysis of AT1R and b-actin (loading control) mRNAs. The AT1R mRNA levels were normalized to b-actin mRNA levels.
Results are expressed as a fold change compared to AT1R mRNA precipitated by IgG. Lower panels show control anti-Flag western blot and
agarose gels with AT1R and b-actin PCR products. (C) p100 interacts with 100–300 of AT1R 30-UTR. A schematic representation of diﬀerent
30-UTR transcripts used as probes in aﬃnity puriﬁcation reactions is shown. Probes were incubated with p100-Flag protein containing cell lysates.
The results are shown as western blot demonstrating bound Flag-p100.
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expression did not aﬀect the binding of p100 to the
100–300 region of 30-UTR (Figure 3C, left panel). In con-
trast, silencing of p100 expression reduced Ago2 binding
to this same region (Figure 3C, right panels). These results
suggest that at least in the absence of RISC activation,
Ago2 is recruited to AT1R 30-UTR by p100.
RISC activationby miR-155 doesnot require thebinding
of p100to AT1R 3’-UTR
Taken into account the RISC-relatedness of published
p100–Ago2 interactions, we next wanted to evaluate
whether p100 had a function in miR-155-induced RISC
activation. We could not detect expression of endogenous
miR-155 in HEK293 (data not shown) or COS-1 cells
(Figure 4A), indicating that the binding of p100 with
30-UTR detected was not dependent on miR-155.
MiR-155 binds to nucleotides 70–90 of AT1R 30-UTR
(22). We therefore analyzed the miR-155 eﬀect on the
luciferase construct with 100 or 300 ﬁrst 30-UTR nucleo-
tides fused after luciferase coding sequence [Luc(1–100)
and Luc(1–300), respectively]. While the transfection
of miR-155 had no eﬀect on the expression of luciferase
30-UTR-less construct (data not shown), it attenuated
the expression of both Luc(1–100) and Luc(1–300)
(Figure 4A). The ﬁnding that miR-155 reduced also the
expression of Luc(1–100) construct indicates that the area
of p100 binding (100–300) is not required for miR-155
function and the formation of active RISC complex.
Anti-miR-155 had no eﬀect consistent with the lack of
miR-155 in these cells.
As a further evidence for the formation of active RISC
at 1–100 region, we observed a clear increase in the bind-
ing of endogenous Ago2 to 1–100 region after miR-155
transfection in subsequent aﬃnity puriﬁcation experi-
ments (Figure 4B, left panels). In contrast, at the same
time, there was no increase in binding of p100, pointing
out that p100 binding to this UTR region is not induced
by miR-155. These results imply that p100 is not a part of
miR-155-induced functional RISC complex. To further
control the speciﬁcity of p100 and Ago2 recruitment
by miR-155, we used 100–300 transcript that lacks the
miR-155 binding site. As was expected, neither the binding
of p100 nor Ago2 was increased after addition of miR-155
(Figure 4B, right panels). These results indicated that the
binding of p100 to 30-UTR is independent of miR-155 and
that p100 is not critical for miR-155 function. Thus p100
interaction with 30-UTR is most probably not related to
miR-155-induced RISC pathway. It appears that there
Figure 2. SN-like domains mediate the p100 interaction with 30-UTR. (A) Mapping of the binding sites of SN-like domains and TD. The same
30-UTR transcripts as in Figure 1C were used in the aﬃnity puriﬁcation reactions with cell lysates prepared from SN-like domains or TD over-
expressing COS-1 cells. The results are shown as a western blot of Flag-tagged protein domains bound to transcripts (upper panel). Below is the
western blot of Flag-tagged TD and SN-like domains from cell lysates. (B) REMSA. COS-1 cells were transfected with empty pSG5 vector, or with
p100-Flag, SN-Flag, or TD-Flag expression constructs. Immunoaﬃnity-puriﬁed Flag-tagged proteins were incubated with biotinylated probes
consisting of the segment of luciferase coding region (Neg, four ﬁrst lanes) or 100–300 probe (four last lanes), as indicated. The unbound probe
was digested by RNAase A. The relative levels of puriﬁed proteins used in REMSA are shown in anti-Flag western blot (bottom panel).
Nucleic Acids Research, 2008, Vol. 36, No. 13 4479exist two independent ways to recruit Ago2 to AT1R
mRNA: the traditional miR-155-mediated way and
p100-mediated way. At the light of our results these two
ways are not competing but p100 creates an additional
way to recruit Ago2 to receptor mRNA.
Overexpression of p100increases expression ofluciferase
construct containing AT1R3’-UTR
To assess the functional consequences of p100–30-UTR
interaction, cellular p100 levels were increased by over-
expression in COS-1 cells and the role of p100 on the
expression of the heterologous reporter bearing the
AT1R 30-UTR was examined. In this assay, the levels of
both luciferase activity and mRNA expressed from the
luciferase-AT1R 30-UTR constructs were monitored.
As shown in Figure 5A (ﬁrst column), the abundance of
luciferase synthesized from Luc(30-UTR)-transfected
cells increased after p100 overexpression. This elevation
of protein expression was associated with increased
levels of chimeric mRNA (Figure 5A second column).
We also tested whether SN-like domains, which mediate
the p100 interaction with 30-UTR, were suﬃcient for p100
functional eﬀects. When TD or SN-like domains were
expressed together with luciferase construct, including
the area showing strongest interaction with p100 (1–300
region), we saw that SN-like domains were functional
alone, whereas the overexpression of TD had no eﬀect
(Figure 5B). Based on these results, p100 increases
AT1R expression and this eﬀect is mediated by SN-like
domains. These data support the notion that p100 upreg-
ulates AT1R expression by increasing AT1R mRNA
levels via 30-UTR.
Figure 3. Ago2 co-puriﬁes with p100. (A) Ago2 is present in same aﬃnity puriﬁcation reactions as p100. A schematic representation of diﬀerent
30-UTR transcripts used in aﬃnity puriﬁcation reactions is shown. In the ﬁrst lane there is the control reaction where a region from luciferase coding
region was used as a probe (Neg). The aﬃnity puriﬁcations were performed with lysates from normal HEK293 cells or from HEK293 cells
overexpressing p100-Flag. Western blots of proteins isolated by RNA aﬃnity puriﬁcation were done with anti-Ago2, anti-p100 and anti-Flag
antibodies. The expression of p100-Flag was also monitored from cell lysates (bottom panel). (B) Ago2 and p100 interact. COS-1 cells were
transfected with empty pSG5 vector or with p100-Flag, SN-Flag or TD-Flag expression constructs, followed by immunoaﬃnity puriﬁcation.
Co-precipitated Ago2 was detected by anti-Ago2 western blotting (upper panel). The relative levels of puriﬁed Flag-tagged proteins were detected
by anti-Flag western blotting (lower panel). (C) Silencing of Ago2 has no eﬀect on p100 binding to 100–300, whereas silencing of p100 inhibits Ago2
binding. COS-1 cells were transfected with negative control siRNA (30nM) or with siRNA targeting Ago2 or p100 (30nM). Corresponding
cell lysates were aﬃnity puriﬁed with a probe spanning 100–300 nucleotides of 30-UTR. Western blots of the bound proteins with anti-p100 and
anti-Ago2 antibodies are shown. Below are the control blots of Ago2, p100 and b-tubulin expression levels in cell lysates.
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Figure 5. Overexpression of p100 or SN-like domains increases the
activity of luciferase construct containing AT1R 30-UTR. A schematic
representation of luciferase constructs used is shown. (A) Overexpres-
sion of p100 increases the expression of luciferase construct containing
30-UTR. COS-1 cells were transfected either with a luciferase coding
region (Luc) or with Luc(30-UTR) construct where luciferase gene was
fused with full-length AT1R 30-UTR, and co-transfected with empty
pSG5 vector, or pSG5 plasmid expressing p100-Flag, together with
renilla luciferase. Cells were either lysed and assayed for ﬁreﬂy and
renilla luciferase activities (upper column) or subjected to RNA extrac-
tion, followed by RT–PCR and quantitative luciferase-PCR (lower
column). Results are shown as a mean of three independent experi-
ments and SD. The values corresponding to transfections with Luc
construct together with empty pSG5 vector was set to one. A repre-
sentative anti-Flag western blot of p100-Flag expression is shown
(bottom panel). (B) SN-like domains increase the activity of Luc
(1–300) construct. COS-1 cells were transfected with Luc(1–300) con-
struct together with empty pSG5 vector, or expression constructs for
p100-Flag, SN-Flag or TD-Flag together with renilla luciferase. Cells
were lysed and assayed for ﬁreﬂy and renilla luciferase activities.
Results are shown as a mean of three independent experiments and
SD. Value corresponding to transfection with Luc(1–300) construct
together with empty pSG5 vector was set to one. An anti-Flag western
blot shows the relative expression levels of p100, SN-like domains
and TD.
Figure 4. MiR-155 does not require p100 to function. (A) MiR-155
inhibits the activity of Luc(1–300) and Luc(1–100) constructs. A sche-
matic representation of the luciferase constructs used in Figure 4A and
30-UTR probes used in Figure 4B is shown. COS-1 cells were trans-
fected with a Luc(1–300) construct with 1–300 nucleotides of 30-UTR,
or Luc(1–100) construct with 1–100 nucleotides of AT1R 30-UTR and
co-transfected with 30nM of negative control miRNA (miControl),
miR-155 or anti-miR-155 together with plasmid expressing renilla
luciferase. Cells were lysed and assayed for ﬁreﬂy and renilla lucifer-
ase activities. Results are shown as a mean of three independent
experiments and SD. The mean luciferase value from miControl-trans-
fected cells was set to one. Below are the agarose gel ﬁgures showing
the expression of miR-155 and 5S detected by PCR. (B) MiR-155
speciﬁcally increases the binding of Ago2 to 1–100 region of 30-UTR,
but not to 100–300 region. MiR-155 has no eﬀect on p100 binding to
either probe. COS-1 cells were transfected with miControl, miR-155
or anti-miR-155. Corresponding cell lysates were aﬃnity puriﬁed by
probes spanning 1–100 or 100–300 nucleotides of the 30-UTR, as indi-
cated. The binding results were analysed by western blot analysis with
anti-Ago2 or anti-p100 antibodies (upper two panels). Below are
the control gels illustrating the expression levels of miR-155 and 5S
(PCR products in agarose gels), and Ago2 and p100 (western blots)
in cell lysates.
Nucleic Acids Research, 2008, Vol. 36, No. 13 4481Downregulation ofp100 expression decreases
AT1Rexpression
Next we used a siRNA-based intervention to reduce p100
expression levels in early-passage coronary artery VSMC.
We found that p100 downregulation leads to a decline in
endogenous AT1R levels as measured by ligand binding
and western blot (Figure 6A). We also saw that sip100
reduced mRNA of endogenous AT1R in VSMCs. Consis-
tent with these results, we observed that silencing of p100
caused about 50% reduction in the luciferase activity of
Luc(30-UTR) and Luc(1–300) constructs in COS-1 cells.
Silencing of p100 had no eﬀect on the 30-UTR-less or
Luc(1–100) constructs lacking the interaction with p100.
Taken together, this data further implies that p100
increases AT1R expression through an interaction with
30-UTR. These data also demonstrated that functional
eﬀects of p100 are similar in COS-1 cells and in VSMCs.
At this point we tested whether Ago2 had functional
eﬀects on AT1R expression in the absence of miR-155.
We observed that Ago2 depletion had no eﬀect on recep-
tor expression measured at the protein and mRNA level
(Figure 6C and D). This suggests that Ago2 has no func-
tion of its own related to the regulation of AT1R expres-
sion but that the eﬀects mediated by Ago2 require the
presence of miR-155. In addition, these results indicate
that the stabilizing eﬀect on AT1R expression exerted by
p100 does not require Ago2.
Identification of thep100-binding site
To test whether the eﬀect of p100 depends on p100
binding to 30-UTR, we mapped the binding site in more
detail. For this purpose, we generated shorter probes of
the 100–300 area and used them in aﬃnity puriﬁcation
assay. We found that p100 requires 30-UTR residues
118–120 for its binding (Figure 7A). The importance of
this site for the function of 30-UTR itself was tested in
luciferase assays. Loss of p100 binding resulted in reduced
luciferase activity (Figure 7B) and the construct became
unresponsive to p100 overexpression (Figure 7C). These
results further underline the importance of p100 binding
for its functional eﬀects.
p100stabilizes AT1RmRNA
To ascertain if the increase in AT1R mRNA levels was
due to changes in mRNA stability, the AT1R half-life was
analysed following actinomycin D treatment to inhibit
de novo transcription. The half-life of AT1R mRNA
with 30-UTR was 4.9h, respectively, whereas the silencing
of p100 expression resulted in the reduction of the mRNA
half-life to 3.1h (Figure 8A). We also studied the eﬀect of
p100 overexpression to AT1R mRNA half-life as a func-
tion of p100 protein level. The half-life of AT1R mRNA
was increased to 6.8h with 50ng, to 7.5h with 100ng and
to 10.8h with the transfection of 200ng of p100 cDNA.
The half-life of the UTR-less AT1R or b-actin mRNA was
not altered by depletion or by overexpression of p100
(data not shown). Thus, p100 aﬀected AT1R mRNA
levels by regulating its stability through speciﬁc binding
to AT1R 30-UTR.
p100 increases AT1R mRNA translation
To examine the eﬀect of p100 on the 30-UTR-regulated
translation, in vitro translation reactions were performed
in the presence of BSA control or immunoaﬃnity-puriﬁed
p100. When the luciferase activities of the translation
products were measured, we found that the addition of
p100 into the reaction together with RNA transcript in
which luciferase coding region was fused with 30-UTR,
Luc(30-UTR), we saw a clear up-regulation of luciferase
translation by  50% (Figure 8B, upper panel). In con-
trast, when p100 was added to the reaction with
30-UTR-less transcript (Luc), there was no eﬀect, consis-
tent with the interpretation that p100 interaction with the
mRNA is essential for its translational eﬀects. Biotin-
labelled translation products were also separated by
SDS–PAGE, electroblotted and detected by streptavidin-
HRP with similar results (Figure 8B, lower panel).
A pulse incubation with
35S, followed by luciferase
IP, revealed a decrease in luciferase translation from the
Luc(30-UTR) mRNA after p100 silencing and increase in
translation after p100 overexpression (Figure 8C).
Translation of mRNA lacking 30-UTR was unaﬀected
by the overexpression or silencing of p100 expression.
These ﬁndings provide an additional demonstration that
p100 enhances AT1R mRNA translation. Together, our
ﬁndings support the notion that the posttranscriptional
regulation of AT1R expression by p100 is elicited through
altered stability and translation, respectively.
DISCUSSION
We found a novel RISC-independent mRNA regulatory
mechanism for p100. Our ﬁndings support a model in
which the SN-like domains of p100 enhance mRNA trans-
lation and repress mRNA degradation by binding to the
30-UTR of AT1R. The eﬀect of p100 on AT1R is mediated
by speciﬁc 30-UTR interaction as the deletion of p100-
binding site and subsequent decrease in p100 binding
removes p100 eﬀects. Calreticulin (20), AUF1 (21) and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH;
J.L. and K.P., unpublished results) bind either the prox-
imal or the distal region of AT1R 30-UTR, and p100 is
thus so far the only protein described to bind to the
100–300 region. The p100 eﬀect is independent of either
Ago2 or miR-155 consistent with the RISC-independent
mRNA regulation by p100. Several lines of evidence indi-
cate that p100 function on AT1R 30-UTR depends on the
level of p100 binding. The eﬀect of p100 increased when
p100 was overexpressed, whereas a decrease in p100 bind-
ing to AT1R 30-UTR either by p100 silencing or by the
deletion of p100 binding site led to a decreased receptor
expression. Thus, our results are consistent with p100
being a positive regulator of AT1R expression.
p100 was ﬁrst identiﬁed as a co-activator for EBNA-2,
and subsequently discovered as co-regulator for Pim-1,
Signal transducer and activator of transcription 6
(STAT6) in interleukin-4-mediated gene regulation, and
STAT5 in prolactin (PRL) signalling (25,28,31,38,39).
The four SN-like domains of p100 resemble staphylococ-
cal nucleases, which are small calcium-dependent enzymes
4482 Nucleic Acids Research, 2008, Vol. 36, No. 13that hydrolyze both DNA and RNA, and also SN-like
domains of p100 have been shown to possess nuclease
activity (23,24). The SN-like domains have been impli-
cated also in protein interactions, and the SN-like
domains of p100, for example, recruit CREB-binding
protein and RNA polymerase II to STAT6 and facilitate
the formation of STAT6 enhanceosome (25). In line with
the function of SN-like domains in protein interactions,
we found that these domains mediated the p100 interac-
tion with Ago2. In accordance with recently published
ﬁndings showing the ability of SN-like domains to medi-
ate RNA binding (37), we identiﬁed that the p100
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Figure 6. Silencing of p100 expression decreases AT1R expression. (A) The eﬀect of p100 silencing on AT1R expression in VSMCs. VSMCs were
transfected with 30nM siRNA for p100 (sip100) or equal amount of control siRNA (siControl). AT1R expression was then quantiﬁed by ligand
binding (left column). Transfected VSMCs were also subjected to RNA extraction, followed by RT–PCR and quantitative AT1R-PCR (right
column). Results are shown as a mean of three independent experiments and SD. The mean mRNA value of siControl-transfected cells was set
to one. Endogenous AT1R was immunoprecipitated from VSMCs and detected by western blotting (upper panel). The expression levels of p100 and
b-tubulin in VSMC lysates are also shown (lowest two panels). (B) Silencing of p100 reduces the activity of Luc(30-UTR) and Luc(1–300) constructs.
A schematic representation of diﬀerent luciferase constructs used is shown. COS-1 cells were transfected with luciferase constructs with or without
regions of 30-UTR, as indicated, and co-transfected with 30 nM sip100 or siControl, together with plasmid expressing renilla luciferase. Cells were
lysed and assayed for ﬁreﬂy and renilla luciferase activities. Results are shown as a mean of three independent experiments and SD. The mean value
of each luciferase construct transfected together with siControl was set to one. Below are the western blots demonstrating the eﬃciency of
the silencing of p100 (left panels) and b-tubulin control blots (right panels). (C) Silencing of Ago2 expression has no eﬀect on luciferase constructs.
This experiment was done as 6B but 30 nM siAgo2 was used instead of sip100. Results are shown as a mean of three independent experiments and
SD. The mean value of each luciferase construct transfected together with siControl was set to one. Below are the representative western blots of
Ago2 (upper panel) and b-tubulin (lower panel) expression. (D) The eﬀect of Ago2 silencing on AT1R mRNA. COS-1 cells were transfected with
30nM siAgo2 or equal amount of siControl. The cells were subjected to RNA extraction, followed by RT–PCR and quantitative AT1R-PCR.
Results are shown as a mean of three independent experiments and SD. The mean mRNA value of siControl-transfected cells was set to one. The
representative expression levels of Ago2 and b-tubulin in cell lysates are shown (lowest two panels).
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Figure 6. Continued.
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Figure 7. Mapping and deletion of the p100-binding site. A schematic of the probes used in the aﬃnity puriﬁcation and luciferase constructs used
in luciferase assays is shown. The schematic also shows the sequence around 118–120 (118–120 shown in bold). (A) Nucleotides 118–120 of AT1R
30-UTR are critical for p100 interaction. A negative control probe (from luciferase coding region; Neg) or diﬀerent 30-UTR probes were incubated
with cell lysates and the binding products were analysed by western blot with anti-p100 antibodies. (B) Deletions of p100-binding site lead to reduced
luciferase activity. COS-1 cells were transfected either with a luciferase coding region only (Luc), with Luc(30-UTR), or with Luc(del 118–120)
constructs, as indicated, and co-transfected with renilla luciferase. Cells were lysed and assayed for ﬁreﬂy and renilla luciferase activities. Results are
shown as a mean of three independent experiments and SD. The luciferase activity corresponding to transfection with Luc construct was set to one.
(C) Deletion of p100 binding site (del 118–120). COS-1 cells were transfected with the same set of luciferase constructs as in (B), and co-transfected
with empty pSG5 vector, or pSG5 plasmid expressing p100-Flag, together with renilla luciferase, as indicated. Cells were lysed and assayed for ﬁreﬂy
and renilla luciferase activities. Results are shown as a mean of three independent experiments and SD. The value corresponding to transfection with
Luc construct together with empty pSG5 vector was set to one. Below is the representative control western blot of p100 expression.
4484 Nucleic Acids Research, 2008, Vol. 36, No. 13interaction with 30-UTR and its functional eﬀects related
to interaction were mediated by SN-like domains.
Whether the interaction between SN-like domains and
30-UTR mRNA is direct or indirect remains uncertain.
The REMSA experiment with GST fusion proteins did
not show any binding suggesting that the interaction of
p100 with AT1R 30-UTR might be indirect. Recently, it
was found that the TD mediates the interaction between
p100 and small nuclear RNPs that function in pre-mRNA
splicing, and that the TD accelerates the kinetics of the
spliceosome assembly (40). Thus p100 is a novel regulator
of gene expression that participates via distinct domains in
both transcription and splicing. In our assays, we did not
see any functional eﬀect speciﬁc for TD. The TD appears
to modulate the speciﬁcity of p100–30-UTR interaction,
since SN-like domains alone showed a slightly diﬀerent
pattern of interaction with 30-UTR compared to the
full-length p100.
As a further evidence for its multifunctional role,
p100 has been indicated in degradation of edited primary
transcripts of some miRNAs (41–43). p100 has been found
also to be a part of RISC with yet unknown function
(24,29). RISC is a multiprotein assembly consisting of pro-
teins with diﬀerent functions and is induced by miRNA
binding to 30-UTR (44,45). Since it is possible that pro-
tein–protein interactions might mediate p100–AT1R
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Figure 8. p100 regulates positively AT1R mRNA stability and translation. (A) p100 silencing and overexpression. COS-1 cells were transfected with
AT1R 30-UTR construct with 30nM of siControl or sip100 (left column) or with increasing amounts of pSG5 vector or p100-Flag (right column).
The half-life of the AT1R mRNA in each p100 expression level condition was ﬁrst plotted as linear ﬁt and the resulting half-lives are shown in
columns. Below are the control western blots for p100 silencing, b-tubulin expression and p100-Flag overexpression. (B) p100 enhances translation.
In vitro translation level of luciferase coding region only (Luc) or of Luc(30-UTR) transcript were compared in the presence or absence of aﬃnity-
puriﬁed p100. BSA was used as a control protein. Luciferase activity was measured from the in vitro translation reaction mixture. The results
represent the means and SD of an average of three independent experiments. The mean luciferase value of the Luc transcript incubated with
BSA was set to one. Biotin-labelled translation products were also detected by blotting with streptavidin-HRP antibodies (lower panel).
(C)
35S incorporation. COS-1 cells were transfected with Luc or Luc(30-UTR) constructs (except sample in the ﬁrst lane) and co-transfected with
pSG5 vector, p100-Flag expression plasmid, siControl or sip100, as indicated. After incubation with
35S-methionine, cells were lysed and subjected
to IP with anti-luciferase antibody. The immunoprecipitated proteins were detected by autoradiography. Results are shown both after p100 over-
expression (upper panel) and p100 silencing (lower panel).
Nucleic Acids Research, 2008, Vol. 36, No. 13 448530-UTR interaction, we pursued the hypothesis that the
binding of p100 to AT1R mRNA 30-UTR would be
mediated by RISC. Ago2, the central engine of RISC and
a known partner of p100, did not mediate this interaction,
since thedepletion ofAgo2did notinﬂuence thep100 bind-
ing to 30-UTR. The consequence of p100–Ago2 complex
formation at 30-UTR remains elusive. We probed the
blots containing aﬃnity puriﬁcation reactions with antibo-
dies against other well-known RISC components (46,47).
We did not detect fragile-X-mental-retardation-related
protein 1 or GW182 protein in the same complex with
p100 and Ago2 (data not shown), implying that p100–
Ago2 complex may no be a functional RISC. The silencing
of Ago2 expression did not have any eﬀect on AT1R
expression at protein or mRNA level, indicating that
Ago2 does not mediate the p100-induced eﬀects on AT1R
mRNA. Interaction of p100 with 30-UTR or the p100-
mediated eﬀects do not depend on RISC as endogenous
miR-155 was not present in COS-1 or HEK293 cells and
that miR-155-induced RISC function did not require p100.
The p100 protein is an evolutionarily conserved protein
present in the genomes of various eukaryotes (28,39,
48–51). It appears that p100 is regulated at posttranscrip-
tional level and that this regulation has also functional
consequences. In our experiments p100 did not mediate
the posttranscriptional regulation of AT1R in response
to estrogen, angiotensin II, atorvastatin, or insulin. The
increase in p100 protein expression during lactation is
a common feature among mammals (52). Accordingly,
our results showing that p100 protein levels are increased
by PRL in mouse mammary epithelial cells further related
increased p100 expression to lactation (38). Interestingly,
rat p100 has been shown to increase in VSMCs in response
to oxidative stress (53). This suggests that reactive oxygen
species-activated expression of p100 may contribute to
the VSMC growth and proliferation. In view of the upre-
gulation of AT1R expression by both oxidative stress and
by p100 overexpression, it will be interesting to study the
relationship of p100 and the increase in AT1R expression
induced by oxidative stress.
p100 is localized both in nucleus and cytoplasm and it
regulates RNA processing in both these compartments.
p100 regulates mRNA maturation, and as shown in this
study, also mRNA stability and translation. Thus, p100
could potentially have a role in coordinating mRNA
metabolism. Many other RBPs, such as embryonic lethal
abnormal vision-like RNA-binding protein HuR, and
alpha-globin poly(C)-binding protein have similar, multi-
layered eﬀects on RNA (54–57). Linking nuclear and cyto-
plasmic controls by the action of a particular RBP may
be of general importance and underscore the intricate
connections thatexist betweenRNA processing in diﬀerent
stages of mRNA life cycle, as we seek a better understand-
ing of the molecular underpinnings of mRNA regulation.
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